about
Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c miceImmunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice.Immunization with Toxoplasma gondii GRA17 Deletion Mutant Induces Partial Protection and Survival in Challenged Mice.The genome of the protozoan parasite Cystoisospora suis and a reverse vaccinology approach to identify vaccine candidates.Recent advances in developing vaccines against Toxoplasma gondii: an update.Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts.Ginseng Stem-and-Leaf Saponin (GSLS)-Enhanced Protective Immune Responses Induced by Toxoplasma gondii Heat Shocked Protein 70 (HSP70) Against Toxoplasmosis in Mice.Immunity in the spleen and blood of mice immunized with irradiated Toxoplasma gondii tachyzoites.In silico analysis and recombinant expression of BamA protein as a universal vaccine against Escherichia coli in mice.Resistance to Chronic Toxoplasma gondii Infection Induced by a DNA Vaccine Expressing GRA16.Induction of specific humoral immune response in mice immunized with ROP18 nanospheres from Toxoplasma gondii.Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route.Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins.Evaluation of the immune response in BALB/c mice induced by a novel DNA vaccine expressing GRA14 against Toxoplasma gondii.Calcium-dependent protein kinases are potential targets for Toxoplasma gondii vaccine.ApiCOWplexa 2013--2nd International Meeting on Apicomplexan Parasites in Farm Animals.Recent progress in microneme-based vaccines development againstImmunization with plasmid DNA expressing Heat Shock Protein 40 confers prophylactic protection against chronic Toxoplasma gondii infection in Kunming mice
P2860
Q23071101-4FD11420-421F-47E3-BB91-DDD9B15A92A5Q33776827-4FB8A873-170E-4498-B6E8-05DB1A17C5AEQ33849618-953341F4-23EE-4623-8550-F295D116C009Q37705239-88082DD9-D781-493B-8E4D-138C28F82B19Q38607376-CC3884EB-2939-47DF-89B7-9A5EF4F66357Q39016116-767E61B2-7221-48D6-A23D-5ECC549F6F1FQ39201614-D73027AE-F245-4C51-9C0F-BA3D7AAC9A97Q39633568-23A278F9-2D91-4CEC-B583-1A57A82C1A7AQ39884742-9AB1C8AA-BCEE-4D30-96D1-DEE4DFA77E48Q40065419-F9BA92AD-DB8C-48E2-B9DE-2534085FA34DQ40482585-6999E790-ACD1-4BB1-A06D-548CC4D4C265Q40498945-7B16CC7D-2F95-4DF0-9DCF-626CA288F3E5Q41017277-1B0FADAC-E355-41C1-94DC-1981F1E7D380Q47840789-222B935F-DE6B-4498-A549-0CE9AA4687F7Q48109140-7DF398FB-59E1-4CF8-B1AD-B327BCB98126Q53085409-9DCEE93C-307E-4441-9C1B-499F580FF3D1Q57177851-59E47C03-31B5-4FD0-9CAB-0E13F645D4F3Q57179393-091E40C0-05DE-42C9-9CDE-EF65C94BB9D3
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Veterinary vaccines against toxoplasmosis.
@en
type
label
Veterinary vaccines against toxoplasmosis.
@en
prefLabel
Veterinary vaccines against toxoplasmosis.
@en
P2860
P1433
P1476
Veterinary vaccines against toxoplasmosis.
@en
P2093
Elżbieta Hiszczyńska-Sawicka
Henryka Długońska
P2860
P304
P356
10.1017/S0031182014000481
P577
2014-05-07T00:00:00Z